{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:49:52Z","timestamp":1767066592192,"version":"3.48.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Microsatellites in melanoma are physically separate from the primary tumor, are hypothesized to arise by lymphovascular invasion similar to other metastases, and\n                    <jats:italic>have not been previously studied at the molecular level<\/jats:italic>\n                    . We compared gene expression in microsatellites with the matched primary melanoma in two patients using spatial transcriptomics. We identified recurrently altered genes in microsatellites contributing to vascular invasion (ITGA4, MCAM), survival in the circulation (CXCL8, PDGFRB, CDH1), vascular exit (ITGB2), survival at metastatic sites (C3, TGBFI), matrix remodeling (MMP9, VCAN, FN1, BGN), and angiogenesis (EMILIN2). Gene set enrichment analysis confirmed a metastatic signature in comparison to genes upregulated and downregulated in distant melanoma metastases, and identified pathway enrichment for NFKB, CDH1, and ZEB1 signaling. Microsatellites exhibited increased host immune responses and four recurrently overexpressed mediators of immune evasion were present (PAEP, GDF15, CD74, HLA-DRA) implying selection pressure from the increased immune response. Seven additional non-recurrent mediators of immune evasion were identified in microsatellites, overexpressed up to 58-fold in microsatellites. PAEP was 275-fold and 25-fold overexpressed, respectively, in microsatellites in two cases. We studied PAEP protein expression by immunohistochemistry in a larger group of 12 and found overexpression in microsatellites in five of 12 patients. PAEP was detected by immunohistochemistry in a microsatellite and also in a subclone within its primary, raising the possibility that the immunostain identifies the subclone in the primary responsible for the microsatellite. These preliminary findings suggest that melanoma microsatellites are true metastases at the level of gene expression, accounting for the sharply increased risk of disease progression in patients with microsatellites.\n                  <\/jats:p>","DOI":"10.1007\/s00428-025-04182-7","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T02:53:22Z","timestamp":1753671202000},"page":"1391-1400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Melanoma microsatellites exhibit a metastatic signature by spatial transcriptomics and overexpress mediators of immune evasion"],"prefix":"10.1007","volume":"487","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4802-2770","authenticated-orcid":false,"given":"Simon J.","family":"Warren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria R.","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3776-5053","authenticated-orcid":false,"given":"Ahmed K.","family":"Alomari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"20","key":"4182_CR1","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","volume":"373","author":"AH Shain","year":"2015","unstructured":"Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A et al (2015) The genetic evolution of melanoma from precursor lesions. N Engl J Med 373(20):1926\u20131936","journal-title":"N Engl J Med"},{"issue":"1","key":"4182_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ccell.2018.06.005","volume":"34","author":"AH Shain","year":"2018","unstructured":"Shain AH, Joseph NM, Yu R, Benhamida J, Liu S, Prow T et al (2018) Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution. Cancer Cell 34(1):45\u201355.e4","journal-title":"Cancer Cell"},{"issue":"3","key":"4182_CR3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1158\/1078-0432.CCR-06-1820","volume":"13","author":"J Jaeger","year":"2007","unstructured":"Jaeger J, Koczan D, Thiesen HJ, Ibrahim SM, Gross G, Spang R et al (2007) Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser- microdissected melanoma tissues. Clin Cancer Res 13(3):806\u2013815","journal-title":"Clin Cancer Res"},{"key":"4182_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1755-8794-1-13","volume":"1","author":"AI Riker","year":"2008","unstructured":"Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C et al (2008) The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 1:13","journal-title":"BMC Med Genomics"},{"issue":"2","key":"4182_CR5","first-page":"903","volume":"20","author":"J Chen","year":"2019","unstructured":"Chen J, Wu F, Shi Y et al (2019) Identification of key candidate genes involved in melanoma metastasis. Mol Med Rep 20(2):903\u2013914","journal-title":"Mol Med Rep"},{"issue":"17","key":"4182_CR6","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1073\/pnas.0501564102","volume":"102","author":"C Haqq","year":"2005","unstructured":"Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam BL et al (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci 102(17):6092\u20136097","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"4182_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA (2017) Emerging biological principles of metastasis. Cell 168(4):670\u2013691","journal-title":"Cell"},{"issue":"2","key":"4182_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10555-021-09960-8","volume":"40","author":"HH Vandyck","year":"2021","unstructured":"Vandyck HH, Hillen LM, Bosisio FM, van den Oord J, Zur Hausen A, Winnepenninckx V (2021) Rethinking the biology of metastatic melanoma: a holistic approach. Cancer Metastasis Rev 40(2):603\u2013624","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"4182_CR9","first-page":"472","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI et al (2017) Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67(6):472\u2013492","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4182_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/00000658-198107000-00019","volume":"194","author":"CL Day Jr","year":"1981","unstructured":"Day CL Jr, Harrist TJ, Gorstein F, Sober AJ, Lew RA, Friedman RJ et al (1981) Malignant melanoma. Prognostic significance of \u201cmicroscopic satellites\u201d in the reticular dermis and subcutaneous fat. Ann Surg 194(1):108\u2013112","journal-title":"Ann Surg"},{"issue":"10","key":"4182_CR11","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/1097-0142(19840515)53:10<2183::AID-CNCR2820531029>3.0.CO;2-9","volume":"53","author":"TJ Harrist","year":"1984","unstructured":"Harrist TJ, Rigel DS, Day CL Jr, Sober AJ, Lew RA, Rhodes AR et al (1984) \u201cMicroscopic satellites\u201d are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer 53(10):2183\u20132187","journal-title":"Cancer"},{"issue":"12","key":"4182_CR12","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1001\/archsurg.1991.01410360031006","volume":"126","author":"P Le\u00f3n","year":"1991","unstructured":"Le\u00f3n P, Daly JM, Synnestvedt M, Schultz DJ, Elder DE, Clark WH Jr (1991) The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg 126(12):1461\u20131468","journal-title":"Arch Surg"},{"issue":"8","key":"4182_CR13","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1200\/JCO.2002.08.024","volume":"20","author":"UN Rao","year":"2002","unstructured":"Rao UN, Ibrahim J, Flaherty LE, Richards J, Kirkwood JM (2002) Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of Eastern Cooperative Oncology Group Trial E1690. J Clin Oncol 20(8):2053\u20132057","journal-title":"J Clin Oncol"},{"issue":"7","key":"4182_CR14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/s41379-020-0500-9","volume":"33","author":"MG Niebling","year":"2020","unstructured":"Niebling MG, Haydu LE, Lo SN, Rawson RV, Lamboo LGE, Stollman JT et al (2020) The prognostic significance of microsatellites in cutaneous melanoma. Mod Pathol 33(7):1369\u20131379","journal-title":"Mod Pathol"},{"issue":"5","key":"4182_CR15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3390\/cells9051151","volume":"9","author":"S Napoli","year":"2020","unstructured":"Napoli S, Scuderi C, Gattuso G, Bella VD, Candido S, Basile MS et al (2020) Functional roles of matrix metalloproteinases and their inhibitors in melanoma. Cells 9(5):1151","journal-title":"Cells"},{"issue":"1","key":"4182_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2353\/ajpath.2010.090748","volume":"177","author":"J Soikkeli","year":"2010","unstructured":"Soikkeli J, Podlasz P, Yin M, Nummela P, Jahkola T, Virolainen S et al (2010) Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth. Am J Pathol 177(1):387\u2013403","journal-title":"Am J Pathol"},{"key":"4182_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","volume":"31","author":"Q Liu","year":"2016","unstructured":"Liu Q, Li A, Tian Y, Wu JD, Liu Y, Li T et al (2016) The CXCL8-CXCR1\/2 pathways in cancer. Cytokine Growth Factor Rev 31:61\u201371","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"4182_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1593\/neo.91604","volume":"12","author":"RB Rebhun","year":"2010","unstructured":"Rebhun RB, Cheng H, Gershenwald JE, Fan D, Fidler IJ, Langley RR (2010) Constitutive expression of the alpha4 integrin correlates with tumorigenicity and lymph node metastasis of the B16 murine melanoma. Neoplasia 12(2):173\u2013182","journal-title":"Neoplasia"},{"issue":"2","key":"4182_CR19","doi-asserted-by":"publisher","first-page":"e70059","DOI":"10.1111\/exd.70059","volume":"34","author":"AD Braun","year":"2025","unstructured":"Braun AD, Mengoni M, T\u00fcting T, Gaffal E (2025) MCAM expression facilitates melanoma-endothelial interactions and promotes metastatic disease progression. Exp Dermatol 34(2):e70059","journal-title":"Exp Dermatol"},{"issue":"25","key":"4182_CR20","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1038\/s41388-017-0107-x","volume":"37","author":"A Paulitti","year":"2018","unstructured":"Paulitti A, Andreuzzi E, Bizzotto D, Pellicani R, Tarticchio G, Marastoni S et al (2018) The ablation of the matricellular protein EMILIN2 causes defective vascularization due to impaired EGFR-dependent IL-8 production affecting tumor growth. Oncogene 37(25):3399\u20133414","journal-title":"Oncogene"},{"issue":"1","key":"4182_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/CMR.0000000000000134","volume":"25","author":"WC Uen","year":"2015","unstructured":"Uen WC, Hsieh CH, Tseng TT, Jiang SS, Tseng JC, Lee SC (2015) Anchorage independency promoted tumor malignancy of melanoma cells under reattachment through elevated interleukin-8 and CXC chemokine receptor 1 expression. Melanoma Res 25(1):35\u201346","journal-title":"Melanoma Res"},{"issue":"1","key":"4182_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2015.02.021","volume":"361","author":"YC Xiao","year":"2015","unstructured":"Xiao YC, Yang ZB, Cheng XS, Fang XB, Shen T, Xia CF et al (2015) CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis. Cancer Lett 361(1):22\u201332","journal-title":"Cancer Lett"},{"key":"4182_CR23","doi-asserted-by":"publisher","first-page":"306879","DOI":"10.1155\/2012\/306879","volume":"2012","author":"YN Kim","year":"2012","unstructured":"Kim YN, Koo KH, Sung JY, Yun UJ, Kim H (2012) Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol 2012:306879","journal-title":"Int J Cell Biol"},{"issue":"10","key":"4182_CR24","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","volume":"68","author":"TT Onder","year":"2008","unstructured":"Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68(10):3645\u20133654","journal-title":"Cancer Res."},{"issue":"7","key":"4182_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri1130","volume":"3","author":"RM Ransohoff","year":"2003","unstructured":"Ransohoff RM, Kivis\u00e4kk P, Kidd G (2003) Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3(7):569\u2013581","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4182_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40478-025-01924-1","volume":"13","author":"JC Kienzler","year":"2025","unstructured":"Kienzler JC, Contreras EM, Treger J, Liau LM, Owens GC, Prins RM (2025) Transcriptome analysis of novel B16 melanoma metastatic variants generated by serial intracarotid artery injection. Acta Neuropathol Commun 13(1):10","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"4182_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cell.2017.02.025","volume":"168","author":"A Boire","year":"2017","unstructured":"Boire A, Zou Y, Shieh J, Macalinao DG, Pentsova E, Massagu\u00e9 J (2017) Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis. Cell 168(6):1101\u20131113","journal-title":"Cell"},{"issue":"6","key":"4182_CR28","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/jid.2014.20","volume":"134","author":"L Lauden","year":"2014","unstructured":"Lauden L, Siewiera J, Boukouaci W, Ramgolam K, Mourah S, Lebbe C et al (2014) TGF-\u03b2-induced (TGFBI) protein in melanoma: a signature of high metastatic potential. J Invest Dermatol 134(6):1675\u20131685","journal-title":"J Invest Dermatol"},{"issue":"6B","key":"4182_CR29","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/j.1582-4934.2009.00922.x","volume":"14","author":"S Ren","year":"2010","unstructured":"Ren S, Liu S, Howell PM Jr et al (2010) Functional characterization of the progestagen-associated endometrial protein gene in human melanoma. J Cell Mol Med 14(6B):1432\u20131442","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4182_CR30","doi-asserted-by":"publisher","first-page":"e0119038","DOI":"10.1371\/journal.pone.0119038","volume":"10","author":"S Ren","year":"2015","unstructured":"Ren S, Chai L, Wang C, Li C, Ren Q, Yang L et al (2015) Human malignant melanoma-derived progestagen-associated endometrial protein immunosuppresses T lymphocytes in vitro. PLoS ONE 10(3):e0119038","journal-title":"PLoS ONE"},{"issue":"1","key":"4182_CR31","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1038\/s41467-023-39817-3","volume":"14","author":"M Haake","year":"2023","unstructured":"Haake M, Haack B, Sch\u00e4fer T, Harter PN, Mattavelli G, Eiring P et al (2023) Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. Nat Commun 14(1):4253","journal-title":"Nat Commun"},{"issue":"6","key":"4182_CR32","doi-asserted-by":"publisher","first-page":"e15122","DOI":"10.1111\/exd.15122","volume":"33","author":"K Tanese","year":"2024","unstructured":"Tanese K, Ogata D (2024) The role of macrophage migration inhibitory factor family and CD74 in the pathogenesis of melanoma. Exp Dermatol 33(6):e15122","journal-title":"Exp Dermatol"},{"issue":"4","key":"4182_CR33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/path.5384","volume":"250","author":"CR Figueiredo","year":"2020","unstructured":"Figueiredo CR, Kalirai H, Sacco JJ, Azevedo RA, Duckworth A, Slupsky JR et al (2020) Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. J Pathol 250(4):420\u2013439","journal-title":"J Pathol"},{"issue":"2","key":"4182_CR34","first-page":"553","volume":"13","author":"M Hoellwerth","year":"2023","unstructured":"Hoellwerth M, Koelblinger P, Lang R, Harrer A (2023) Revisiting the role of the CXCL13\/CXCR5-associated immune axis in melanoma: potential implications for anti-PD-1-related biomarker research. Life (Basel) 13(2):553","journal-title":"Life (Basel)"},{"issue":"2","key":"4182_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/biom14020171","volume":"14","author":"A Mlynska","year":"2024","unstructured":"Mlynska A, Gibavi\u010dien\u0117 J, Kutanovait\u0117 O, Senkus L, Ma\u017eeikait\u0117 J, Ker\u0161evi\u010di\u016bt\u0117 I et al (2024) Defining melanoma immune biomarkers-desert, excluded, and inflamed subtypes-using a gene expression classifier reflecting intratumoral immune response and stromal Patterns. Biomolecules 14(2):171","journal-title":"Biomolecules"},{"issue":"4","key":"4182_CR36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41591-019-0356-z","volume":"25","author":"MEW Logtenberg","year":"2019","unstructured":"Logtenberg MEW, Jansen JHM, Raaben M, Toebes M, Franke K, Brandsma AM et al (2019) Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRP\u03b1 axis and a target for cancer immunotherapy. Nat Med 25(4):612\u2013619","journal-title":"Nat Med"},{"issue":"1","key":"4182_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1051\/vcm\/2022008","volume":"4","author":"Y Liu","year":"2023","unstructured":"Liu Y, Shi Y, Wang P (2023) Functions of glutaminyl cyclase and its isoform in diseases. Vis Cancer Med 4(1):1\u201314","journal-title":"Vis Cancer Med"},{"issue":"17","key":"4182_CR38","first-page":"5381","volume":"63","author":"W Ruf","year":"2003","unstructured":"Ruf W, Seftor EA, Petrovan RJ, Weiss RM, Gruman LM, Margaryan NV et al (2003) Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Res 63(17):5381\u20135389","journal-title":"Cancer Res"},{"issue":"29","key":"4182_CR39","doi-asserted-by":"publisher","first-page":"46492","DOI":"10.18632\/oncotarget.10216","volume":"7","author":"LY Tan","year":"2016","unstructured":"Tan LY, Mintoff C, Johan MZ, Ebert BW, Fedele C, Zhang YF et al (2016) Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome. Oncotarget 7(29):46492\u201346508","journal-title":"Oncotarget"},{"issue":"5","key":"4182_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1586\/14737140.2014.883281","volume":"14","author":"HJ Chung","year":"2014","unstructured":"Chung HJ, Mahalingam M (2014) Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma - implications for therapeutic strategies and targeted therapies. Expert Rev Anticancer Ther 14(5):621\u2013639","journal-title":"Expert Rev Anticancer Ther"},{"issue":"24","key":"4182_CR41","doi-asserted-by":"publisher","first-page":"10340","DOI":"10.1158\/0008-5472.CAN-10-0705","volume":"70","author":"KM Hardy","year":"2010","unstructured":"Hardy KM, Kirschmann DA, Seftor EA, Margaryan NV, Postovit LM, Strizzi L et al (2010) Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Res 70(24):10340\u201310350","journal-title":"Cancer Res"},{"issue":"6","key":"4182_CR42","doi-asserted-by":"publisher","first-page":"9717","DOI":"10.18632\/oncotarget.14206","volume":"8","author":"KL Boylan","year":"2017","unstructured":"Boylan KL, Buchanan PC, Manion RD, Shukla DM, Braumberger K, Bruggemeyer C et al (2017) The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate. Oncotarget 8(6):9717\u20139738","journal-title":"Oncotarget"},{"issue":"4","key":"4182_CR43","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s11864-022-00940-w","volume":"23","author":"H Hashimoto","year":"2022","unstructured":"Hashimoto H, Tanaka Y, Murata M, Ito T (2022) Nectin-4: a novel therapeutic target for skin cancers. Curr Treat Options Oncol 23(4):578\u2013593","journal-title":"Curr Treat Options Oncol"},{"key":"4182_CR44","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fonc.2020.00220","volume":"10","author":"MA Andonegui-Elguera","year":"2020","unstructured":"Andonegui-Elguera MA, Alfaro-Mora Y, C\u00e1ceres-Guti\u00e9rrez R, Caro-S\u00e1nchez CHS, Herrera LA, D\u00edaz-Ch\u00e1vez J (2020) An overview of vasculogenic mimicry in breast cancer. Front Oncol 10:220","journal-title":"Front Oncol"},{"issue":"43","key":"4182_CR45","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4182_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J et al (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34(3):267\u2013273","journal-title":"Nat Genet"},{"issue":"12","key":"4182_CR47","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/jnci\/djn174","volume":"100","author":"M Sch\u00f6n","year":"2008","unstructured":"Sch\u00f6n M, Wienrich BG, Kneitz S, Sennefelder H, Amschler K, V\u00f6hringer V et al (2008) KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment. J Natl Cancer Inst 100(12):862\u2013875","journal-title":"J Natl Cancer Inst"},{"issue":"49","key":"4182_CR48","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1038\/sj.onc.1210508","volume":"26","author":"K Aigner","year":"2007","unstructured":"Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M et al (2007) The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26(49):6979\u20136988","journal-title":"Oncogene"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04182-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:01:59Z","timestamp":1767063719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04182-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4182"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04182-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"type":"print","value":"0945-6317"},{"type":"electronic","value":"1432-2307"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}